Your browser doesn't support javascript.
loading
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies.
Tam, Constantine S; Dimopoulos, Meletios; Garcia-Sanz, Ramon; Trotman, Judith; Opat, Stephen; Roberts, Andrew W; Owen, Roger; Song, Yuqin; Xu, Wei; Zhu, Jun; Li, Jianyong; Qiu, Lugui; D'Sa, Shirley; Jurczak, Wojciech; Cull, Gavin; Marlton, Paula; Gottlieb, David; Munoz, Javier; Phillips, Tycel; Du, Chenmu; Ji, Meng; Zhou, Lei; Guo, Haiyi; Zhu, Hongjie; Chan, Wai Y; Cohen, Aileen; Novotny, William; Huang, Jane; Tedeschi, Alessandra.
Afiliación
  • Tam CS; Department of Hematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Dimopoulos M; Department of Hematology, St Vincent's Hospital, Fitzroy, VIC, Australia.
  • Garcia-Sanz R; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Trotman J; Department of Clinical Hematology, Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Opat S; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Roberts AW; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.
  • Owen R; Department of Hematology, Concord Repatriation Hospital, Concord, NSW, Australia.
  • Song Y; Department of Hematology, The University of Sydney, Concord, NSW, Australia.
  • Xu W; Department of Clinical Hematology, Monash Health, Clayton, VIC, Australia.
  • Zhu J; Department of Hematology, Monash University, Clayton, VIC, Australia.
  • Li J; Blood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Qiu L; The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • D'Sa S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.
  • Jurczak W; Department of Hematology, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China.
  • Cull G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.
  • Marlton P; Department of Hematology, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China.
  • Gottlieb D; National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Munoz J; Cancer Division, University College London Hospital Foundation Trust, London, UK.
  • Phillips T; Department of Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Du C; Department of Hematology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Ji M; Department of Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia.
  • Zhou L; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Guo H; School of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Zhu H; Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Sydney, NSW, Australia.
  • Chan WY; Department of Hematology, Banner MD Anderson Cancer Center, Gilbert, AZ.
  • Cohen A; Division of Hematology and Oncology, University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Novotny W; BeiGene (Beijing) Co., Ltd, Beijing, China.
  • Huang J; BeiGene USA, Inc., San Mateo, CA; and.
  • Tedeschi A; BeiGene USA, Inc., San Mateo, CA; and.
Blood Adv ; 6(4): 1296-1308, 2022 02 22.
Article en En | MEDLINE | ID: mdl-34724705
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía / Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Linfoma de Células B / Linfoma Folicular / Sepsis / Dolor Musculoesquelético / Hipertensión Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía / Fibrilación Atrial / Leucemia Linfocítica Crónica de Células B / Linfoma de Células B / Linfoma Folicular / Sepsis / Dolor Musculoesquelético / Hipertensión Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Australia